Literature DB >> 11572790

Activin A and activin receptors in gestational tissue from preeclamptic pregnancies.

U Manuelpillai1, M Schneider-Kolsky, A Dole, E M Wallace.   

Abstract

Maternal serum activin A levels are elevated in women with preeclampsia. To explore whether this could be due, at least in part, to increased production by the gestational tissues, we have measured activin A in the serum of women with (n=23) or without preeclampsia (n=62) at 29-40 weeks of gestation and in placenta and fetal membranes from preterm preeclamptic (PT-PE, n=8), term preeclamptic (T-PE, n=10) and healthy term controls (T-C, n=10). We have also explored if there are associated changes in activin receptor Alk2, ActRII and ActRIIB in these tissues. The relative amounts of receptor proteins were measured by densitometry on Western blots and receptors and activin beta(A) subunit localised by immunohistochemistry in PT-PE, T-PE and T-C gestational tissues (n=8-10/group). Maternal serum activin A levels were significantly elevated in women with preeclampsia (multiples of the normal median (MoM)=3.5, P<0.0001, Mann-Whitney U test) compared with healthy women (median MoM=1.0). Compared with control tissues, the activin A content was significantly higher in preeclamptic placentae (P=0.001 and P=0.0005 for PT-PE and T-PE respectively, Mann-Whitney U test), but significantly lower in the amnion (P=0.005 and P=0.014 for PT-PE and T-PE respectively) and choriodecidua (P=0.009 for T-PE). The maternal serum activin A level in women with preeclampsia was significantly correlated with elevated placental production (P=0.01, Pearson's correlation). Receptor Alk2 protein levels were significantly elevated in T-PE placentae (P=0.0006, Mann-Whitney U test), ActRIIB levels were significantly lower in PT-PE placentae (P=0.01) and ActRII levels were significantly lower in PT-PE choriodecidua (P=0.0002) compared with controls. There were no apparent differences in the distribution of the beta(A) subunit and receptors Alk2, ActRII and ActRIIB between control and preeclamptic tissues. These findings suggest that elevated levels of activin A in the maternal circulation in association with preeclampsia are due, at least in part, to increased placental production, and that the regulation of activin synthesis in placenta and fetal membranes is differentially regulated. Further, the differences in activin receptor protein levels between preeclamptic and control placenta and choriodecidua suggest that activin A-induced regulation may be altered in preeclampsia.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11572790     DOI: 10.1677/joe.0.1710057

Source DB:  PubMed          Journal:  J Endocrinol        ISSN: 0022-0795            Impact factor:   4.286


  5 in total

Review 1.  Role of placenta in preeclampsia.

Authors:  Leslie Myatt
Journal:  Endocrine       Date:  2002-10       Impact factor: 3.633

Review 2.  Defective Uteroplacental Vascular Remodeling in Preeclampsia: Key Molecular Factors Leading to Long Term Cardiovascular Disease.

Authors:  Kirim Hong; Soo Hyun Kim; Dong Hyun Cha; Hee Jin Park
Journal:  Int J Mol Sci       Date:  2021-10-18       Impact factor: 5.923

3.  Sustained Elevated Circulating Activin A Impairs Global Longitudinal Strain in Pregnant Rats: A Potential Mechanism for Preeclampsia-Related Cardiac Dysfunction.

Authors:  Bhavisha A Bakrania; Ana C Palei; Umesh Bhattarai; Yingjie Chen; Joey P Granger; Sajid Shahul
Journal:  Cells       Date:  2022-02-21       Impact factor: 6.600

Review 4.  Melatonin for the Management of Preeclampsia: A Review.

Authors:  Annie Langston-Cox; Sarah A Marshall; Daisy Lu; Kirsten R Palmer; Euan M Wallace
Journal:  Antioxidants (Basel)       Date:  2021-03-03

Review 5.  The TGFβ Family in Human Placental Development at the Fetal-Maternal Interface.

Authors:  Susana M Chuva de Sousa Lopes; Marta S Alexdottir; Gudrun Valdimarsdottir
Journal:  Biomolecules       Date:  2020-03-13
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.